SAN DIEGO, May 2, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it will release first quarter 2013 financial results on Thursday, May 9, 2013 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Thursday, May 9, 2013 at 5:00 p.m. ET.
The call may be accessed by dialing (877) 755-7422 (domestic) or (678) 894-3067 (international) five minutes prior to start time and providing the passcode 53245436. A link to the live webcast may be accessed by visiting the "Investors" section of the Company's website at http://ir.verenium.com/. A replay of the event will be available on the Company's website approximately two hours after the call and will be archived for 30 days.
Verenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes. Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets. Read more at www.verenium.com.
Forward Looking Statements
Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty. These include, but are not limited to, statements related to Verenium's ability to develop and/or commercialize its products, diversify its product portfolio, enhance its manufacturing capabilities, capture near-ter
|SOURCE Verenium Corporation|
Copyright©2012 PR Newswire.
All rights reserved